CIK 0002100782
- Emerging growth company
Generate Biomedicines, Inc.
Sign in to watch- Ticker
- GENB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831630228
- Phone
- +1 888-469-0055
- Business address
- 101 SOUTH STREET, SUITE 900, SOMERVILLE, MA, 02143
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Planned sale Director sold 11,409 shares at $16.19 ($184,733)
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 1,000 shares at $16.00 ($16,002)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chief Executive Officer bought 20,000 shares at $12.00 ($240,000)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief People Officer bought 300 shares at $16.00 ($4,800)
- 4 Derivatives Options or other derivatives
Page 1 of 3 · 58 filings